Anti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis
Over the past 30 years, the majority of (pre)clinical efforts to find an effective therapy for Alzheimer’s disease (AD) focused on clearing the β-amyloid peptide (Aβ) from the brain since, according to the amyloid cascade hypothesis, the peptide was (and it is still considered by many) the pathogeni...
Main Author: | Ernesto Fedele |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/19/14499 |
Similar Items
-
he amyloid hypothesis of Alzheimer's disease: past and present, hopes and disappointments
by: I. V. Litvinenko, et al.
Published: (2019-11-01) -
The Amyloid Cascade Hypothesis in Alzheimer’s Disease: Should We Change Our Thinking?
by: Markku Kurkinen, et al.
Published: (2023-03-01) -
Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer’s Disease
by: Md. Sahab Uddin, et al.
Published: (2020-08-01) -
Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer’s Disease
by: Tapan Behl, et al.
Published: (2020-10-01) -
Anti-Amyloid-β Monoclonal Antibodies: Recent Therapeutic Strategies for Alzheimer’s Disease
by: Maria Teresa Cruz, et al.
Published: (2022-03-01)